VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

Related Keywords

United States ,Texas ,Houston ,Geoffrey Lucks ,Eric Peden ,Hala Barakat ,Jenniferl Horspool ,Timothy Boire ,Jason Burgess ,Tim Boire ,Venostent Selfwrap Bioabsorbable Perivascular ,Mark Barakat ,Clinical Affairs Mark Barakat ,News Network ,Clinical Affairs ,Venostent Inc ,National Science Foundation ,Breakthrough Technology ,National Principal Investigator ,National Institute Of Health ,Venostent Co ,Stent Enrolls First Subjects ,Fistulas Clinical Trial ,Surgical Specialists ,Vascular Surgeons ,Selfwrap Bioabsorbable Perivascular Wrap ,Venostent Director ,Project Coordinator Hala Barakat ,Surgeon Jason Burgess ,Venostent Co Founders ,Vascular Surgery ,Houston Methodist Hospital ,National Institute ,Good Growth Capital ,Looking Statements ,